TENS in Scleroderma
Start Date
10/1/2024
Completion Date
5/1/2026
Summary
The goal of this pilot study is to assess the acceptability of the transcutaneous electrical acustimulation (TEA) device in treating Scleroderma-related gastroparesis. The main objective is: To evaluate the acceptability of TEA as an intervention for alleviating symptoms of distension and bloating in individuals diagnosed with Scleroderma. Participants will be provided with the TEA devices that will be applied to the skin for a total of 45 minutes twice daily after meals. Participants will be asked to fill out both daily diaries and biweekly questionnaires to assess for improvement in the gastroparesis symptoms. Participants will also be asked to complete the daily diaries in addition weekly questionnaires during a 4 week post-treatment follow-up period.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Transcutaneous Electrical Nerve Stimulation
Conditions
Locations
University of Michigan
Ann Arbor, Michigan 48912
United States